Free Trial

Madrigal Pharmaceuticals (MDGL) SEC Filings & 10K Form

Madrigal Pharmaceuticals logo
$308.44 +15.03 (+5.12%)
(As of 12/20/2024 05:31 PM ET)

Recent Madrigal Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/05/2024
3:46 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:16 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:10 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:30 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:18 PM
Madrigal Pharmaceuticals (Subject)
PAULSON & CO. INC. (Filed by)
Form SC 13G/A
11/14/2024
5:30 AM
Madrigal Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/08/2024
4:07 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:01 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:47 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:32 PM
Madrigal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/31/2024
8:02 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
6:05 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
7:36 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
8:51 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
8:29 PM
Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:16 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
6:52 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
7:58 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:06 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
8:46 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
8:41 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
8:42 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
8:42 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
8:45 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:03 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:28 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
8:39 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
8:44 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:17 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
3:37 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:45 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:53 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
4:03 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
4:39 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
5:48 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
8:36 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
8:53 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:06 PM
Madrigal Pharmaceuticals (Filer)
Form S-3ASR
05/07/2024
8:00 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:06 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
04/29/2024
3:49 PM
Madrigal Pharmaceuticals (Filer)
Form DEF 14A
04/10/2024
7:50 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
7:53 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
7:50 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
7:50 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:41 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:44 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:47 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:22 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:21 PM
BAKER BROS. ADVISORS LP (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:28 PM
BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
03/21/2024
3:30 PM
Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2024
3:11 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:10 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:01 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
5:32 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
1:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
8:21 AM
Avoro Capital Advisors LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
4:55 PM
JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
01/25/2024
5:04 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:50 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:54 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
10:13 AM
Madrigal Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
12:52 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
12:39 PM
Howarth Alex G. (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
12:45 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
12:46 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
12:47 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
12:45 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MDGL) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners